SQUADRITO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 4.884
EU - Europa 4.412
AS - Asia 1.599
SA - Sud America 7
OC - Oceania 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.912
Nazione #
US - Stati Uniti d'America 4.843
IE - Irlanda 1.361
SE - Svezia 1.183
CN - Cina 870
SG - Singapore 589
IT - Italia 536
UA - Ucraina 372
DE - Germania 362
FI - Finlandia 207
GB - Regno Unito 107
PL - Polonia 102
IN - India 87
BE - Belgio 54
FR - Francia 41
CA - Canada 39
RU - Federazione Russa 22
AT - Austria 19
ID - Indonesia 17
NL - Olanda 14
CZ - Repubblica Ceca 13
IR - Iran 11
VN - Vietnam 8
ES - Italia 7
CL - Cile 4
BD - Bangladesh 3
CH - Svizzera 3
RO - Romania 3
AU - Australia 2
AZ - Azerbaigian 2
BR - Brasile 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
KH - Cambogia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
JP - Giappone 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
VE - Venezuela 1
Totale 10.912
Città #
Dublin 1.361
Chandler 963
Jacksonville 803
Nyköping 656
Singapore 506
Ashburn 476
Beijing 308
Princeton 201
Medford 189
Messina 177
Ann Arbor 163
Cambridge 150
Des Moines 150
Boardman 123
Warsaw 102
Dearborn 96
New York 79
Woodbridge 66
Wilmington 62
Jinan 58
Brussels 54
Helsinki 53
Munich 47
Rome 46
Shenyang 45
Nanjing 42
Hebei 40
Los Angeles 39
Hyderabad 38
Nuremberg 38
Pune 37
San Mateo 37
Bremen 35
Ottawa 35
Houston 33
Haikou 32
Lancaster 29
Guangzhou 27
Ningbo 26
Tianjin 26
Seattle 25
Zhengzhou 25
Hangzhou 21
Nanchang 21
Rosolini 21
Taizhou 18
Catania 17
Jakarta 16
Vienna 16
Auburn Hills 14
Changsha 13
Fuzhou 12
Lanzhou 11
Ardabil 10
Hefei 10
Milan 10
Norwalk 10
Avola 9
Tappahannock 9
Washington 9
Augusta 8
Brno 8
Dong Ket 8
Falls Church 8
Jiaxing 7
Lappeenranta 7
Leawood 7
Tilburg 7
Madrid 6
Monmouth Junction 6
Scandicci 6
Sortino 6
Taiyuan 6
Chicago 5
Lamezia Terme 5
Qingdao 5
Shanghai 5
Caltagirone 4
Harbin 4
Mumbai 4
Novokuznetsk 4
Pachino 4
Regensburg 4
Saint Petersburg 4
Strasbourg 4
Amsterdam 3
Belpasso 3
Bucharest 3
Changle 3
Chengdu 3
Clearwater 3
Moscow 3
Palermo 3
Redwood City 3
Siculiana 3
Wuhan 3
Baku 2
Baoding 2
Bari 2
Clifton 2
Totale 7.928
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 270
Adenosine Receptor Stimulation by Polydeoxyribonucleotide Improves Tissue Repair and Symptomology in Experimental Colitis. 132
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 111
Atrial fibrillation in patients with cirrhosis 105
null 103
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 99
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 97
Valutazione elastografica (fibroscan) del fegato nelle pazienti con sindrome di Turner 96
Activation of the cholinergic anti-inflammatory pathway reduces NF-kappa B activation, blunts TNF-alpha production, and protects against splanchnic artery occlusion shock 92
Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension 90
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 89
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 88
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 84
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 83
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 82
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 81
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 81
Inhibition of nuclear factor-kappa B activation by IRFI 042, protects against endotoxin-induced shock 77
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 77
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 77
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 75
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 75
HCV NS5A mutations and response of chronic hepatitis to alpha interferon. 72
17 beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat 72
null 70
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 70
Abnormal left ventricular global strain during exercise-test in young healthy smokers 70
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 69
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 69
Reduction of carbon tetrachloride-induced rat liver injury by IRFI 042, a novel dual vitamin E-like antioxidant. 69
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury 69
G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS 68
Effects of cloricromene on the levels of endothelin and on the microcirculatory function in peripheral atherosclerotic arteriopathies 68
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 68
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 68
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 68
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 67
Effect of beta blockade on the erythrocyte transport of Na+: evaluation during stimulation by cold pressure test in patients with essential hypertension] 66
ANTIBODIES AGAINST INTERCELLULAR-ADHESION MOLECULE-1 PROTECT AGAINST MYOCARDIAL ISCHEMIA-REPERFUSION INJURY IN RAT 66
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 66
Expression and change of mirs 145, 221 and 222 in hypertensive subjects treated with enalapril, losartan or olmesartan 66
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 66
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 66
Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury 65
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 65
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 65
CENTRAL DIPSOGENIC EFFECT OF SYNTHETIC RAT ATRIAL NATRIURETIC POLYPEPTIDE IN NORMOTENSIVE RATS 65
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 65
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 65
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 64
Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury 64
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 64
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 63
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 63
Endotoxin tolerance impairs a pertussis-toxin-sensitive G- protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats 63
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 63
Effect of sulfatide on acute lung injury during endotoxemia in rats 62
Cardiovascular effects of raloxifene hydrochloride 62
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two–Lipid Center Real-World Experience 62
Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats. 61
Clinical virology of hepatitis B virus infection 61
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 61
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 61
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 61
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 61
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 61
Evaluation of liver stiffness using transient elastography (fibroscan) in young adults with Turner syndrome. 60
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 60
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 60
Hepatitis C virus genome complexity correlates with response to interferon therapy: A study in French patients with chronic hepatitis C 59
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 59
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 59
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 59
Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease 58
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 58
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 58
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 58
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock 57
Efferent vagal fibre stimulation blunts nuclear factor-kappa B activation and protects against hypovolemic hemorrhagic shock 57
Fibroscan: a new non invasive method for cross-sectional and longitudinal evaluation of liver dysfunction in Turner syndrome 57
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 57
Nutraceuticals: A New Challenge against Cadmium‐Induced Testicular Injury 57
Evidence for a role of nuclear factor-kappa B in acute hypovolemic hemorrhagic shock 56
Inhibition of tumour necrosis factor and reversal of endotoxin- induced shock by U-83836E, a 'second generation' lazaroid in rats 56
PARTICIPATION OF TUMOR-NECROSIS-FACTOR AND NITRIC-OXIDE IN THE MEDIATION OF VASCULAR DYSFUNCTION IN SPLANCHNIC ARTERY- OCCLUSION SHOCK 56
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 56
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 55
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappa B and reduces the inflammatory response in myocardial ischaemia-reperfusion injury 55
Protective effects of Cyclosporin-A in splanchnic artery occlusion shock 55
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 54
Beneficial effect of raxofelast, an hydrophilic vitamin E analogue, in the rat heart after ischemia and reperfusion injury 54
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 54
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice 54
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 53
Recombinant human granulocyte colony-stimulating factor reverts vascular dysfunction 52
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 52
Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis 52
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 52
Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection 51
Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection 51
Totale 6.945
Categoria #
all - tutte 52.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020882 0 0 0 0 0 0 172 190 17 262 220 21
2020/20211.301 146 16 351 56 69 130 31 144 93 124 94 47
2021/20221.482 25 168 36 42 97 7 99 59 29 297 171 452
2022/20233.924 286 386 165 283 287 407 67 230 1.611 26 132 44
2023/20241.275 76 139 62 121 82 223 14 272 4 86 76 120
2024/2025934 107 60 83 279 211 185 9 0 0 0 0 0
Totale 11.250